As an identical candidate, miR-3646 has been shown to be an important regulator responsible to Doc-resistant phenotype of breast cancer cells, and manipulates GSK-3β-dependent activation of β-catenin signaling pathway. This evidence concerns the gene GSK3B and breast cancer.